Allantoin
A keratolytic and skin-softening agent that calms irritation and accelerates desquamation of damaged cells.
Increases cell proliferation, softens keratin (mild keratolysis), and forms complexes with irritants to neutralise them.
- Calms irritation
- Softens skin
- Supports recovery of minor wounds
- Universal tolerability
What the evidence supports.
- All skin types
No notable contraindications reported.
Mid-routine serum or treatment step.
Concentration range in well-formulated products: 0.1%–2%
Year-round.
Endogenous metabolite of uric acid.
No specific deficiency signals tracked for this ingredient.
Inexpensive workhorse soothing ingredient, included in most calming formulas.
The research behind Allantoin.
Every claim on this page traces to published research. Findings below are drawn from randomized trials and systematic reviews, each links to the study on PubMed.
Inflammation and Allergy Drug Targets, 2014
Cutis, 2006
No flagged conflicts. Still, patch-test new actives.
Sign up to see how Allantoin fits your skin archetype and personalised protocol.
1 study from the Intelligence Vault that discuss Allantoin.
Browse the Vault →